Home/Filings/4/0000805928-25-000134
4//SEC Filing

Burke William P. Mr. 4

Accession 0000805928-25-000134

CIK 0000805928other

Filed

Nov 6, 7:00 PM ET

Accepted

Nov 7, 4:52 PM ET

Size

14.9 KB

Accession

0000805928-25-000134

Insider Transaction Report

Form 4
Period: 2025-11-05
Transactions
  • Exercise/Conversion

    Common Stock

    2025-11-05$8.14/sh+11,431$93,04811,531 total
  • Sale

    Common Stock

    2025-11-05$24.05/sh11,431$274,893100 total
  • Exercise/Conversion

    Common Stock

    2025-11-06$8.14/sh+5,347$43,5255,447 total
  • Exercise/Conversion

    Stock Option (right to purchase)

    2025-11-0511,43128,165 total
    Exercise: $8.14Exp: 2032-07-11Common Stock (11,431 underlying)
  • Exercise/Conversion

    Stock Option (right to purchase)

    2025-11-065,34722,818 total
    Exercise: $8.14Exp: 2032-07-11Common Stock (5,347 underlying)
  • Sale

    Common Stock

    2025-11-06$24.01/sh5,347$128,371100 total
Footnotes (3)
  • [F1]The sale reported on this Form 4 was made pursuant to a Rule 10b5-1(c) trading plan adopted March 14, 2025. The price reported in column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $24.00 to $24.25 per share. The Reporting Person hereby undertakes to provide upon request by the staff of the Securities and Exchange Commission, the issuer, or a security holder of the issuer, full information regarding the number of shares sold at each separate price.
  • [F2]The sale reported on this Form 4 was made pursuant to a Rule 10b5-1(c) trading plan adopted March 14, 2025. The price reported in column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $24.00 to $24.06 per share. The Reporting Person hereby undertakes to provide upon request by the staff of the Securities and Exchange Commission, the issuer, or a security holder of the issuer, full information regarding the number of shares sold at each separate price.
  • [F3]This grant vested in three equal annual installments on the annual anniversary of the grant date, July 11, 2022.

Issuer

Axogen, Inc.

CIK 0000805928

Entity typeother

Related Parties

1
  • filerCIK 0001682069

Filing Metadata

Form type
4
Filed
Nov 6, 7:00 PM ET
Accepted
Nov 7, 4:52 PM ET
Size
14.9 KB